Skip to content

Price / book at other companies

Amgen logo
AmgenAMGN
20.6×-6.3×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
2.6×+0.2×
Gilead Sciences logo
Gilead SciencesGILD
7.4×+0.1×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
3.1×+1.3×
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
+0.6×
Nuvation Bio logo
Nuvation BioNUVB
4.7×+3.2×

Other financials

Income statement

See full
Revenue-$29.0K-101%
Gross profit$1.2M-60.2%
Operating income-$132.3M+5.2%
Net income-$125.7M-3.9%
EPS (diluted)-$0.85+3.4%

Balance sheet

See full
Cash & equivalents$283.0M-23.1%
Total debt$95.6M-0.5%
Total equity$812.8M-22.1%
Total assets$1.0B-21.6%

Cash flow

See full
Operating cash flow-$132.4M-69.5%
CapEx$390.0K-76.1%
Free cash flow-$132.8M-66.5%

Valuation

See full
Market cap$1.71B+61.1%
Enterprise value$1.53B+102%
P/S26.2×-24.8×

Profitability

See full
Gross margin96.1%-2.7pp
Operating margin-720.8%-313pp
Net margin-676%-291pp
FCF margin-686.5%-273pp

Returns & leverage

See full
Return on equity-47.7%+3.6pp
Debt / equity0.1×0.0×
Current ratio7.1×+0.3×

Where this comes from

Calculated from Vir Biotechnology, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s price / book?
Vir Biotechnology, Inc. (VIR) reported price / book of 1.8× in Q1 2026.
How has Vir Biotechnology, Inc.'s price / book changed year-over-year?
Vir Biotechnology, Inc.'s price / book increased by 106.9% year-over-year, from 0.9× to 1.8×.
What is the long-term trend for Vir Biotechnology, Inc.'s price / book?
Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s price / book has grown at a -25.8% compound annual growth rate (CAGR), from 4.9× to 1.1×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.